Filing Details
- Accession Number:
- 0000904454-14-000646
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-15 22:53:30
- Reporting Period:
- 2014-09-11
- Filing Date:
- 2014-09-15
- Accepted Time:
- 2014-09-15 21:53:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1457612 | Genocea Biosciences Inc. | GNCA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591868 | Baker Jessica Flechtner | C/O Genocea Biosciences, Inc. 100 Acorn Drive, 5Th Floor Cambridge MA 02140 | Vp Of Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-11 | 840 | $1.67 | 840 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-11 | 840 | $12.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-09-11 | 3,663 | $2.38 | 3,683 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-11 | 3,663 | $12.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-09-12 | 1,680 | $1.67 | 1,680 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-09-12 | 420 | $1.67 | 2,100 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-12 | 420 | $12.00 | 1,680 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-09-12 | 1,456 | $2.38 | 3,136 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-12 | 1,456 | $12.00 | 1,680 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-09-12 | 56 | $2.38 | 1,736 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-12 | 56 | $12.00 | 1,680 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-09-11 | 840 | $0.00 | 840 | $1.67 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-09-11 | 3,663 | $0.00 | 3,663 | $2.38 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-09-12 | 1,680 | $0.00 | 1,680 | $1.67 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-09-12 | 420 | $0.00 | 420 | $1.67 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-09-12 | 1,456 | $0.00 | 1,456 | $2.38 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-09-12 | 56 | $0.00 | 56 | $2.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-01-22 | No | 4 | M | Direct | |
| 4,740 | 2019-06-29 | No | 4 | M | Direct | |
| 0 | 2017-05-14 | No | 4 | M | Direct | |
| 0 | 2017-08-19 | No | 4 | M | Direct | |
| 3,284 | 2019-06-29 | No | 4 | M | Direct | |
| 3,228 | 2019-06-29 | No | 4 | M | Direct |
Footnotes
- The option vested 25% on 01/23/09 and the remainder in equal monthly installments for the next three years thereafter.
- The option vested 6.25% on 06/30/09 and the remainder in equal monthly installments for the next four years thereafter.
- The option vested 25% on 05/15/08 and the remainder in equal monthly installments for the next three years thereafter.
- The option vested 25% on 08/20/07 and the remainder in equal monthly installments for the next three years thereafter.
Billionaire Hedge Funds
